Leerink on Zura Bio Ltd. (ZURA): 'We continue to see positive readthrough from NVS' Ph 2 ianalumab'
Tweet Send to a Friend
Leerink Partners analyst Faisal A. Khurshid reiterated an Outperform rating and $11.00 price target on Zura Bio Ltd. (NASDAQ: ZURA).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
